MiMedx Group, Inc. (MDXG)
4.28
-0.05
(-1.15%)
USD |
NASDAQ |
Aug 24, 16:00
4.28
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Price : 4.28 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 4.30 | 4.35 | 4.25 | 4.33 | 897111.0 |
| Aug 20, 2026 | 4.40 | 4.47 | 4.28 | 4.30 | 1.433M |
| Aug 19, 2026 | 4.37 | 4.50 | 4.365 | 4.45 | 1.160M |
| Aug 18, 2026 | 4.20 | 4.37 | 4.20 | 4.34 | 1.220M |
| Aug 17, 2026 | 4.26 | 4.28 | 4.175 | 4.19 | 898512.0 |
| Aug 14, 2026 | 4.19 | 4.315 | 4.12 | 4.27 | 974771.0 |
| Aug 13, 2026 | 4.28 | 4.31 | 4.165 | 4.20 | 1.068M |
| Aug 12, 2026 | 4.32 | 4.375 | 4.265 | 4.28 | 729380.0 |
| Aug 11, 2026 | 4.29 | 4.36 | 4.265 | 4.32 | 1.229M |
| Aug 10, 2026 | 4.31 | 4.39 | 4.215 | 4.27 | 1.156M |
| Aug 07, 2026 | 4.19 | 4.385 | 4.14 | 4.34 | 1.362M |
| Aug 06, 2026 | 4.16 | 4.22 | 4.05 | 4.18 | 1.390M |
| Aug 05, 2026 | 4.27 | 4.28 | 4.12 | 4.16 | 1.469M |
| Aug 04, 2026 | 4.27 | 4.39 | 4.165 | 4.27 | 1.807M |
| Aug 03, 2026 | 4.21 | 4.485 | 4.21 | 4.27 | 1.869M |
| Jul 31, 2026 | 4.17 | 4.21 | 3.972 | 4.13 | 2.988M |
| Jul 30, 2026 | 3.90 | 4.27 | 3.76 | 4.27 | 6.116M |
| Jul 29, 2026 | 4.41 | 4.455 | 4.215 | 4.23 | 1.434M |
| Jul 28, 2026 | 4.30 | 4.45 | 4.26 | 4.36 | 1.119M |
| Jul 27, 2026 | 4.24 | 4.395 | 4.204 | 4.26 | 1.163M |
| Jul 24, 2026 | 4.17 | 4.23 | 4.14 | 4.20 | 531893.0 |
| Jul 23, 2026 | 4.12 | 4.22 | 4.11 | 4.13 | 868551.0 |
| Jul 22, 2026 | 4.32 | 4.35 | 4.09 | 4.17 | 1.070M |
| Jul 21, 2026 | 4.29 | 4.335 | 4.25 | 4.32 | 1.111M |
| Jul 20, 2026 | 4.30 | 4.35 | 4.225 | 4.33 | 737039.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Anika Therapeutics, Inc. | 21.31 |
| Perspective Therapeutics, Inc. | 3.18 |
| ABVC BioPharma, Inc. | 0.8444 |
| Enovis Corp. | 25.22 |
| Edwards Lifesciences Corp. | 90.50 |
Price Related Metrics
| PE Ratio | 108.35 |
| PS Ratio | 1.796 |
| Price to Book Value | 2.887 |
| Price to Free Cash Flow | 15.07 |
| Earnings Yield | 0.92% |
| Market Cap | 623.70M |
| Operating PE Ratio | 72.88 |
| Normalized PE Ratio | 108.63 |